Good morning, and welcome to Agenus Inc.'s fourth-quarter and year-end 2024 earnings conference call. Currently, all ...

Agenus (AGEN) shares slipped in morning trade after the company missed fourth quarter revenue estimates. The company reported ...

Q4 2024 Earnings Call Transcript March 11, 2025 Agenus Inc. beats earnings expectations. Reported EPS is $-2.04, expectations ...

Agenus Inc (AGEN) reports reduced operational burn and promising clinical developments, despite a significant net loss and ...

Baird lowered the firm’s price target on Agenus (AGEN) to $3 from $6 and keeps a Neutral rating on the shares. The firm updated its model ...

Agenus Inc. (“Agenus” or the “Company”) (Nasdaq: AGEN), an immuno-oncology company advancing innovative cancer therapies, ...

Reports Q4 revenue $26.84M, consensus $30.09M. “In line with our strategic objectives, we significantly reduced our annualized operational burn ...

LEXINGTON, Mass. (AP) — LEXINGTON, Mass. (AP) — Agenus Inc. (AGEN) on Tuesday reported a loss of $46.8 million in its fourth quarter. The Lexington, Massachusetts-based company said it had a ...

Good morning and welcome to Agenus Inc.'s Fourth Quarter and Year-End 2024 Earnings Conference Call. Currently all participants are in a listen-only mode. A question-and-answer session will follow ...

Agenus Inc. (AGEN) experienced a notable premarket stock increase of 9.77% following the release of its Q4 2024 earnings report. The company reported a Q4 2024 revenue of $26.8 million and a net ...